Ostatní
Návod 
Belite Bio, Inc
BLTE
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
3.7B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-67
PS
0
Cena 1R
49-170
⌀ Cena
86.17
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
16-03-2026
Poslední dividenda
Profil
Belite Bio, Inc, společnost zabývající se vývojem biopfarmaceutických léků v klinickém stádiu, se zabývá výzkumem a vývojem nových léčebných metod zaměřených na atrofickou věkem podmíněnou makulární degeneraci a autosomálně recesivní stargardtova onemocnění. Jeho hlavní kandidátem je LBS-008, perorální léčba jednou denně, která může snížit a udržet dodávku vitaminu A do oka, aby se snížila akumulace toxických vedlejších produktů vitaminu A v oční tkáni, která je ve fázi 3 klinického hodnocení. Společnost také vyvíjí LBS-009, perorální antiretinol vázající protein 4, který se zaměřuje na onemocnění jater, včetně nealkoholického tukového onemocnění jater, nealkoholické steatohepatitidy a diabetu typu 2, který je v preklinické vývojové fázi. Společnost Belite Bio, Inc. byla založena v roce 2016 a sídlí v kalifornském San Diegu. Společnost Belite Bio, Inc. působí jako dceřiná společnost společnosti Lin Bioscience International Ltd.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
25
Založení
2022-04-29
Podobné společnosti
$ 68.58
+ $ 0.47
$ 203.65
+ $ 1.17
$ 14.45
- $ 0.08
$ 166.74
- $ 1.48
$ 22.42
- $ 0.15
$ 24.00
- $ 0.23
$ 36.93
+ $ 0.16
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenues | 0.00 | 0.00 | 0.00 | 399.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | -399.00 | 0.00 | 0.00 | 0.00 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 24,844.00 | 8,869.00 | 7,419.00 | 3,688.00 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 6,824.00 | 3,952.00 | 2,378.00 | 2,055.00 | |
| Depreciation & Amortization | 0.00 | 0.00 | 449.00 | 139.00 | 387.00 | 161.00 | 29.00 | |
| Total Operating Expenses | 84,208.00 | 84,208.00 | 39,996.00 | 31,668.00 | 12,821.00 | 9,797.00 | 5,743.00 | |
| Operating Income | -84,208.00 | -84,208.00 | -39,996.00 | -31,668.00 | -12,821.00 | -9,797.00 | -5,743.00 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,862.00 | 8,743.00 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,093.00 | 2,218.00 | ||
| Depreciation & Amortization | -84.00 | 0.00 | 42.00 | 42.00 | 0.00 | 34.75 | 34.75 | 34.75 | 34.75 | 16.00 | ||
| Total Operating Expenses | 28,077.00 | 23,018.00 | 17,596.00 | 15,517.00 | 11,457.00 | 9,740.00 | 10,471.00 | 8,328.00 | 6,955.00 | 10,961.00 | ||
| Operating Income | -28,077.00 | -23,018.00 | -17,596.00 | -15,517.00 | -11,457.00 | -9,740.00 | -10,471.00 | -8,328.00 | -6,955.00 | -10,961.00 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.00 | 3,737.00 | 74.00 | 23.00 | 5.00 | 12.00 | |
| Interest Expense | 0.00 | 0.00 | 20.00 | 25.00 | 16.00 | 0.00 | 21.00 | |
| Other Expense | 6,597.00 | 6,597.00 | 3,858.00 | 45.00 | 173.00 | 131.00 | -9.00 | |
| IBT | -77,611.00 | -77,611.00 | -36,138.00 | -31,623.00 | -12,648.00 | -9,666.00 | -5,752.00 | |
| Income Tax Expense | 0.00 | 0.00 | 6.00 | 9.00 | -173.00 | 126.00 | 1.00 | |
| Net Income | -77,611.00 | -77,611.00 | -36,144.00 | -31,632.00 | -12,475.00 | -9,792.00 | -5,753.00 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Other Expense | 2,753.00 | 1,328.00 | 1,276.00 | 1,240.00 | 1,357.00 | 1,061.00 | 977.00 | 463.00 | -36.00 | 27.00 | ||
| IBT | -25,324.00 | -21,690.00 | -16,320.00 | -14,277.00 | -10,100.00 | -8,679.00 | -9,494.00 | -7,865.00 | -6,991.00 | -10,934.00 | ||
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.00 | -1.00 | 1.00 | ||
| Net Income | -25,324.00 | -21,690.00 | -16,320.00 | -14,277.00 | -10,100.00 | -8,679.00 | -9,494.00 | -7,871.00 | -6,991.00 | -10,935.00 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.19 | $-0.62 | $-0.41 | $-0.24 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.19 | $-0.62 | $-0.41 | $-0.24 | |
| Shares Outstanding | 33,538.16 | 33,538.16 | 30,538.38 | 26,593.00 | 19,976.60 | 24,095.32 | 24,095.32 | |
| Diluted Shares Outstanding | 33,538.16 | 33,538.16 | 30,538.38 | 26,593.67 | 19,976.60 | 24,095.32 | 24,095.32 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.25 | $-0.40 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.25 | $-0.40 | ||
| Shares Outstanding | 33,538.16 | 33,223.23 | 32,585.04 | 32,084.00 | 31,453.00 | 30,687.31 | 30,324.13 | 29,677.17 | 28,316.25 | 27,315.55 | ||
| Diluted Shares Outstanding | 33,538.16 | 33,223.23 | 32,585.04 | 32,084.00 | 31,453.00 | 30,687.31 | 30,324.13 | 29,677.17 | 28,316.25 | 27,315.55 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 95,500.00 | 31,677.00 | 88,157.00 | 42,089.00 | 17,344.00 | 25,618.00 | |
| Short Term Investments | 0.00 | 113,472.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Cash & ST Investments | 95,500.00 | 145,149.00 | 88,157.00 | 42,089.00 | 17,344.00 | 25,618.00 | |
| Accounts Receivable | 0.00 | 594.00 | 867.00 | 19.00 | 23.00 | 40.00 | |
| Inventory | 0.00 | 0.00 | 0.00 | -19.00 | 0.00 | 0.00 | |
| Other Current Assets | 968.00 | 1,330.00 | 916.00 | 718.00 | 0.00 | 0.00 | |
| Total Current Assets | 113,858.00 | 147,073.00 | 89,940.00 | 42,807.00 | 17,431.00 | 25,668.00 |
| Current Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 0.00 | 0.00 | 31,677.00 | 0.00 | 95,500.00 | 95,500.00 | 88,157.00 | 54,500.00 | 57,400.00 | 37,800.00 | |
| Short Term Investments | 0.00 | 0.00 | 113,472.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Cash & ST Investments | 0.00 | 0.00 | 145,149.00 | 0.00 | 95,500.00 | 95,500.00 | 88,157.00 | 54,500.00 | 57,400.00 | 37,800.00 | |
| Accounts Receivable | 0.00 | 0.00 | 594.00 | 0.00 | 0.00 | 0.00 | 867.00 | 0.00 | 0.00 | 0.00 | |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Current Assets | 150,970.00 | 159,287.00 | 1,330.00 | 111,268.00 | 18,358.00 | 968.00 | 916.00 | 56,135.00 | 59,137.00 | 38,423.00 | |
| Total Current Assets | 150,970.00 | 159,287.00 | 147,073.00 | 111,268.00 | 113,858.00 | 96,468.00 | 89,940.00 | 56,135.00 | 59,137.00 | 38,423.00 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 0.00 | 965.00 | 1,301.00 | 1,378.00 | 94.00 | 66.00 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 3,991.00 | 3,235.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long-Term Assets | 4,572.00 | 103.00 | 166.00 | 88.00 | 823.00 | 7.00 | |
| Total Long-Term Assets | 4,572.00 | 5,059.00 | 4,702.00 | 1,466.00 | 917.00 | 73.00 | |
| Total Assets | 118,430.00 | 152,132.00 | 94,642.00 | 44,273.00 | 18,348.00 | 25,741.00 |
| Long-Term Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 0.00 | 0.00 | 965.00 | 0.00 | 0.00 | 0.00 | 1,301.00 | 0.00 | 0.00 | 0.00 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 0.00 | 0.00 | 3,991.00 | 0.00 | 0.00 | 0.00 | 3,235.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long-Term Assets | 5,437.00 | 4,914.00 | 103.00 | 4,553.00 | 4,572.00 | 4,679.00 | 166.00 | 1,463.00 | 1,558.00 | 1,395.00 | |
| Total Long-Term Assets | 5,437.00 | 4,914.00 | 5,059.00 | 4,553.00 | 4,572.00 | 4,679.00 | 4,702.00 | 1,463.00 | 1,558.00 | 1,395.00 | |
| Total Assets | 156,407.00 | 164,201.00 | 152,132.00 | 115,821.00 | 118,430.00 | 101,147.00 | 94,642.00 | 57,598.00 | 60,695.00 | 39,818.00 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Short-Term Debt | 0.00 | 276.00 | 308.00 | 198.00 | 0.00 | 0.00 | |
| Other Current Liabilities | 0.00 | 5,774.00 | 3,325.00 | 1,906.00 | 1,635.00 | 972.00 | |
| Current Liabilities | 0.00 | 6,050.00 | 3,633.00 | 2,104.00 | 1,635.00 | 972.00 |
| Current Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Short-Term Debt | 0.00 | 0.00 | 276.00 | 0.00 | 0.00 | 0.00 | 308.00 | 0.00 | 0.00 | 0.00 | |
| Other Current Liabilities | 6,522.00 | 6,131.00 | 5,774.00 | 3,621.00 | 3,837.00 | 4,677.00 | 3,325.00 | 0.00 | 0.00 | 0.00 | |
| Current Liabilities | 6,522.00 | 6,131.00 | 6,050.00 | 3,621.00 | 3,837.00 | 4,677.00 | 3,633.00 | 4,804.00 | 4.98 | 4,649.00 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.00 | 261.00 | 578.00 | 668.00 | 0.00 | 0.00 | |
| Capital Leases | 0.00 | 537.00 | 886.00 | 866.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 4,677.00 | 6,311.00 | 4,211.00 | 2,772.00 | 33,441.00 | 32,778.00 |
| Long-Term Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.00 | 0.00 | 261.00 | 0.00 | 0.00 | 0.00 | 578.00 | 0.00 | 0.00 | 0.00 | |
| Capital Leases | 0.00 | 0.00 | 537.00 | 0.00 | 0.00 | 0.00 | 578.00 | 0.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Liabilities | 6,522.00 | 6,131.00 | 6,311.00 | 3,621.00 | 3,837.00 | 4,677.00 | 4,211.00 | 4,804.00 | 4,978.00 | 4,649.00 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Common Stock | 0.00 | 3.00 | 3.00 | 3.00 | 1.00 | 1.00 | |
| Retained Earnings | 0.00 | -107,647.00 | -71,503.00 | -39,871.00 | -27,223.00 | -17,557.00 | |
| Comprehensive Income | 0.00 | -660.00 | -374.00 | -392.00 | -196.00 | -44.00 | |
| Total Common Equity | 114,593.00 | 145,821.00 | 90,431.00 | 41,501.00 | -15,093.00 | -7,037.00 |
| Total Common Equity | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 149,885.00 | 158,070.00 | 3.00 | 112,200.00 | 114,593.00 | 96,470.00 | 3.00 | 52,794.00 | 55.72 | 35.17 | |
| Retained Earnings | 0.00 | 0.00 | -107,647.00 | 0.00 | 0.00 | 0.00 | -71,503.00 | 0.00 | 0.00 | 0.00 | |
| Comprehensive Income | 0.00 | 0.00 | -660.00 | 0.00 | 0.00 | 0.00 | -374.00 | 0.00 | 0.00 | 0.00 | |
| Total Common Equity | 149,885.00 | 158,070.00 | 145,821.00 | 112,200.00 | 114,593.00 | 96,470.00 | 90,431.00 | 52,794.00 | 55,717.00 | 35,169.00 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Debt | 0.00 | 537.00 | 886.00 | 866.00 | 0.00 | 0.00 | |
| Book Value | 113,753.00 | 145,821.00 | 90,431.00 | 41,501.00 | -15,093.00 | -7,037.00 |
| Other | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book Value | 149,885.00 | 158,070.00 | 145,821.00 | 112,200.00 | 114,593.00 | 96,470.00 | 90,431.00 | 52,794.00 | 55,717.00 | 35,169.00 |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Income | -32.61 | -36,144.00 | -31,632.00 | -12,648.00 | -9,666.00 | -5,753.00 | |
| Depreciation & Amortization | 0.00 | 449.00 | 399.00 | 198.00 | 30.00 | 17.00 | |
| Stock-Based Compensation | 3.82 | 8,987.00 | 3,823.00 | 1,483.00 | 1,530.00 | 1,363.00 | |
| Change Working Capital | 0.00 | 1,133.00 | -2,427.00 | -491.00 | 640.00 | -69.00 | |
| Change In Accounts Receivable | 0.00 | 74.00 | -72.00 | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-cash Items | 28.79 | -3,659.00 | 4,693.00 | 0.00 | -8.00 | 0.00 | |
| Cash from Operations | 0.00 | 0.00 | -29,837.00 | -11,458.00 | -7,474.00 | -4,442.00 |
| Cash Flow From Operating Activities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -9.49 | -14.28 | -10.10 | -8.68 | -9.49 | -7.87 | -6.99 | -10.94 | -6.81 | -6.90 | |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 8.99 | 0.00 | 0.00 | 0.00 | 3.82 | 0.00 | 0.00 | 0.00 | |
| Change Working Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-cash Items | 9.49 | 14.28 | 1.11 | 8.68 | 9.49 | 7.87 | 3.17 | 10.94 | 6.81 | 6.90 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.00 | -116.00 | -63.00 | -394.00 | -74.00 | -20.00 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | 0.00 | -188,265.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales of Investment | 0.00 | 77,844.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 18.00 | 0.00 | |
| Cash from Investing | 0.00 | 0.00 | -63.00 | -394.00 | -56.00 | -20.00 |
| Cash Flow From Investing Activities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales of Investment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2,450.00 | |
| Debt Issued | 0.00 | -349.00 | 20.00 | 866.00 | 0.00 | 2,450.00 | |
| Issuance of Common Stock | 0.00 | 0.00 | 77,189.00 | 0.00 | 0.00 | 500.00 | |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | 0.00 | 0.00 | 75,959.00 | 36,963.00 | -583.00 | 30,009.00 | |
| Cash from Financing | 0.00 | 0.00 | 75,959.00 | 36,963.00 | -583.00 | 28,059.00 |
| Cash Flow From Financing Activities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Debt Issued | 0.00 | -537.00 | 537.00 | 0.00 | 0.00 | -886.00 | 886.00 | 0.00 | 0.00 | -866.00 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash position | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Change in Cash | 16,700.00 | -56,480.00 | 46,068.00 | 24,745.00 | -8,274.00 | 23,601.00 | |
| Closing Cash Balance | 0.00 | 31,677.00 | 88,157.00 | 42,089.00 | 17,344.00 | 25,618.00 |
| Cash position | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2,900.00 | 19,600.00 | 0.00 | |
| Closing Cash Balance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 54,500.00 | 57,400.00 | 0.00 |
| Free Cash Flow | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | -29,385.00 | -29,900.00 | -11,852.00 | -7,548.00 | -4,462.00 | |
| Real Free Cash Flow | -3.82 | -38,372.00 | -33,723.00 | -13,335.00 | -9,078.00 | -5,825.00 |
| Free Cash Flow | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Real Free Cash Flow | 0.00 | 0.00 | -8.99 | 0.00 | 0.00 | 0.00 | -3.82 | 0.00 | 0.00 | 0.00 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -66.8 | -67.8 | -1.4 |
| P/S | 0 | 0 | 9.4 |
| P/B | 34.6 | 12.9 | 5.2 |
| P/FCF | -576907.1 | -241031.7 | -1.5 |
| Market cap | $3.7 | $2.2 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 0.2 % | 0 % |
| Debt to Income | 0 % | 1 % | 0 % |
| Debt to Free cash flow | 0 % | -69.7 % | 0 % |
| Interest expense percentage | 0 % | 0.1 % | 44.7 % |
| Current ratio | 23.1 | 13 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -51.8 % | 68.7 % | 0 % |
| ROA | -49.6 % | -50.5 % | 0 % |
| CapEx to Revenue | 0 % | 0 % | 0 % |
| RaD to Revenue | 0 % | 0 % | 0 % |
| ROEM | 0.0 | 0 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 0 % | 0 % | 68.7 % |
| Operating margin | 0 % | 0 % | 35.5 % |
| Net margin | 0 % | 0 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 33.2 mil | 24.5 mil |
| Employee count | 0.0 tis | 0.0 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
